Quantum Healthcare AGM backs board, renews capital and buy-back mandates

Memorial Day Sale – Claim 70% Off TipRanksUnlock trusted, data-backed investing tools with TipRanks Premium, from analyst ratings and forecasts to breaking news and portfolio analysis. Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Quantum Healthcare Ltd. ( (SG:V8Y) ) has shared an update. Quantum Healthcare Ltd. reported that all resolutions at its fourth annual general meeting were passed by poll with unanimous support from shareholders present or by proxy. Shareholders adopted the audited financial statements for the year ended 31 December 2025 and approved directors’ fees of S$145,000 for the 2026 financial year, signalling continuity in the company’s remuneration and reporting policies. The meeting confirmed the re-election of chief executive officer Dr. Gian Siong Lin Jimmy and independent directors Ross Yu Limjoco and Chong Eng Wee, consolidating the current leadership team appointed earlier in 2026. Investors also renewed mandates authorising directors to issue new shares and to conduct share buy-backs, as well as reappointing Forvis Mazars LLP as auditors, providing management with continued flexibility over capital management and affirming confidence in the company’s governance structure. More about Quantum Healthcare Ltd. Quantum Healthcare Ltd., incorporated in Singapore and listed on the SGX Catalist board, operates in the healthcare sector and is governed by an independent-led board that includes a chief executive officer and several independent directors. The company’s governance framework reflects Catalist compliance requirements and relies on external auditors and corporate service providers to support its financial reporting and shareholder meeting processes. Current Market Cap: S$12.59M For an in-depth examination of V8Y stock, go to TipRanks’ Overview page.